A major breakthrough in cancer investigation is emerging with the use of nanobodies to reactivate mutated p53. This crucial cancer inhibitor protein is frequently inactivated in several kinds of malignancies, causing https://bookmarkyourpage.com/story7495485/vhh-fragments-restore-tumor-suppressor-p53-the-new-pathway-for-cancer-treatment